Amarin Corporation plc Message Board

Here's their listing of types of attendees:

Managed Care Executives
Pharmacy Directors
Medical Directors
Academia
Professional Relations
Outcomes Research Professionals
Medical Affairs Pharmacist
Clinical Coordinators
Case Managers/RNs
Residents and Fellows
Student Pharmacists

And here's an example from the schedule. AMRN will also participate in The Exchange (see above post):

11:30 am - 12:00 pm Purdue Pharma L.P.
  Middle-of-the-Night Awakenings: Matching Insomnia Therapy to Patient Need
  Diagnosis and appropriate management of insomnia are important aspects of patient care. Attend the Purdue Pharma L.P. Product Theater “Middle-of-the-Night Awakenings: Matching Insomnia Therapy to Patient Need” to learn about a treatment option now available.
Speaker: Russell Rosenberg, PhD
   
11:30 am - 12:00 pm Forest Pharmaceuticals, Inc.
  This program will evaluate the impact of COPD, review the 2011 GOLD guidelines, discuss goals for improving lung function and present a treatment option for the management of COPD.
Speaker: Shari Fine, DO
   
12:15 pm - 12:45 pm VIVUS, Inc.
  A New Once-Daily Treatment for Obesity
  This program will evaluate the impact of obesity on related risk factors and discuss the clinical guidelines and evolving treatment landscape in obesity.
Speaker: Barbara Troupin, MD, MBA
   
12:15 pm - 12:45 pm AMARIN
  Vascepa™: A new therapy for the treatment of severe hypertriglyceridemia
   
Friday, October 5th

 
   
8:30 am - 9:00 am Pfizer Inc
  Neuropathic Pain Associated with Spinal Cord Injury
  This 30-minute presentation will focus on characterization of neuropathic pain associated with spinal cord injury and its personal and societal burden. Dr. Liss will present clinical trial data and important managed care perspectives. This presentation will include a question-and answer session.
Speaker:
Jonathan L. Liss, MD
Medical Director
Muscogee Manor & Rehabilitation Center
Columbus, GA

Sentiment: Strong Buy